Fibrates are widely used drugs in hyperlipidemic disorders. In addition to lowering serum triglyceride levels, fibrates have also been shown to reduce elevated plasma plasminogen activator inhibitor-1 (PAI-1) levels in vivo. We demonstrate that fibrates suppress PAI-1 synthesis in cultured cynomolgus monkey hepatocytes in a concentration dependent way (0.1 to 1.0 mmol/L) and independent of their lipid-lowering effect. Different fibrates showed different potency in suppressing PAI-1 production: gemfibrozil and clofibric acid, at a concentration of 1 mmol/L, reduced PAI-1 synthesis over 24 hours to 52±20% and 60±5%, while clofibrate and bezafibrate lowered PAI- 1 synthesis to only 86±17% and 84±15% of control values, respectively. These chang...
Pemafibrate (PEM) is a novel lipid-lowering drug classified as a selective peroxisome proliferator-a...
The liver plays a central role in the production and metabolism of lipoproteins, with adipose tissue...
An elevated plasma fibrinogen level is increasingly accepted as an independent risk indicator of car...
Fibrates are used to lower plasma triglycerides and cholesterol levels in hyperlipidemic patients. I...
Abstract—Treatment with fibrates, a widely used class of lipid-modifying agents, results in a substa...
Plasma fibrinogen levels have been identified as an important risk factor for cardiovascular disease...
The molecular mechanism by which hypolipidemic fibrates and antidiabetic thiazolidinediones exert th...
The hypolipidemic fibrates and antidiabetic thiazolidinediones display potent triglyceride-lowering ...
Fibrates are hypolipidemic drugs that affect the expression of genes involved in lipid metabolism by...
Hepatic triacylglycerol (TAG) homeostasis is maintained by carefully regulated balance between its s...
The influence of different fibrates on apolipoprotein metabolism was investigated. Administration of...
Chemicals/CAS: 5,8,11,14-Eicosatetraynoic Acid, 1191-85-1; Antilipemic Agents; Apolipoprotein A-I; F...
International audiencePeroxisome proliferator-activated receptor alpha (PPARa) activation by fibrate...
In view of the evidence linking plasma high density lipopro-tein (HDL)-cholesterol levels to a prote...
Dyslipidaemia is a major risk factor in the development of atherosclerosis, and lipid lowering is ac...
Pemafibrate (PEM) is a novel lipid-lowering drug classified as a selective peroxisome proliferator-a...
The liver plays a central role in the production and metabolism of lipoproteins, with adipose tissue...
An elevated plasma fibrinogen level is increasingly accepted as an independent risk indicator of car...
Fibrates are used to lower plasma triglycerides and cholesterol levels in hyperlipidemic patients. I...
Abstract—Treatment with fibrates, a widely used class of lipid-modifying agents, results in a substa...
Plasma fibrinogen levels have been identified as an important risk factor for cardiovascular disease...
The molecular mechanism by which hypolipidemic fibrates and antidiabetic thiazolidinediones exert th...
The hypolipidemic fibrates and antidiabetic thiazolidinediones display potent triglyceride-lowering ...
Fibrates are hypolipidemic drugs that affect the expression of genes involved in lipid metabolism by...
Hepatic triacylglycerol (TAG) homeostasis is maintained by carefully regulated balance between its s...
The influence of different fibrates on apolipoprotein metabolism was investigated. Administration of...
Chemicals/CAS: 5,8,11,14-Eicosatetraynoic Acid, 1191-85-1; Antilipemic Agents; Apolipoprotein A-I; F...
International audiencePeroxisome proliferator-activated receptor alpha (PPARa) activation by fibrate...
In view of the evidence linking plasma high density lipopro-tein (HDL)-cholesterol levels to a prote...
Dyslipidaemia is a major risk factor in the development of atherosclerosis, and lipid lowering is ac...
Pemafibrate (PEM) is a novel lipid-lowering drug classified as a selective peroxisome proliferator-a...
The liver plays a central role in the production and metabolism of lipoproteins, with adipose tissue...
An elevated plasma fibrinogen level is increasingly accepted as an independent risk indicator of car...